Alex Goldberg

NASDAQ Active Stock Watch List: EnteroMedics Inc. (NASDAQ:ETRM) and Amazon.com Inc. (NASDAQ:AMZN) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/12/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding EnteroMedics Inc. (NASDAQ:ETRM) and Amazon.com Inc. (NASDAQ:AMZN).

EnteroMedics Inc. (NASDAQ:ETRM) a development stage medical device company that focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders is currently up (+7.41%) on 1,660,587 shares traded after EnteroMedics Reported Fourth Quarter 2013 Financial Results. EnteroMedics Inc. (NASDAQ:ETRM) is currently up (+211.11%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about EnteroMedics Inc. (NASDAQ:ETRM)

Amazon.com Inc. (NASDAQ:AMZN) a company that operates as an online retailer in North America and internationally is currently down (-2.44%) on 1,363,438 shares traded after Amazon.com has been downgraded to Neutral from Buy at UBS. Amazon.com Inc. (NASDAQ:AMZN) is currently down (-13%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Amazon.com Inc. (NASDAQ:AMZN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com